Canopy Growth, Constellation Brands, And Irrational Exuberance

10/19/18

Summary

Purchase price of Canopy drove the valuation to irrational levels.

There is not enough potential revenue in the entire country of Canada to substantiate the current valuation of Canopy.

Constellation will pay dearly for this move at a later time; both stocks will move lower over time.

I have a real love/hate relationship with the recent mega-deal of Canopy Growth (CGC) and Constellation Brands (STZ). My knee-jerk reaction was like many others that the end result of this would be a strategic alliance for both companies. Beer companies are not exactly swimming in growth opportunities; diversification to find new opportunities to increase revenues makes sense. At the same time, Canopy would get a huge partner with a massive distribution network. Plus, Canopy's balance sheet would be greatly improved. However, I think Constellation paid far too much with their 50% premium of a stock that already had a premium. I am not alone in this thinking; Constellation's stock sold off on the news. Canopy's valuation is now some C16 billion. The current valuation of Canopy makes no sense, and, dare I say it, there is a great deal of irrational exuberance in this valuation. There will not be enough revenue coming from the Canadian recreational cannabis segment to support the valuation. I think the stock is overbought and will move lower. As for Constellation, eventually, they will have to annotate this purchase on their books (due to happen in 2021), and I do not believe this will bode well for the stock. While I believe in the long-term potential of cannabis and the opportunities the emerging sector represents, I think Canopy's stock is overpriced, and I think Constellation's stock will take a subsequent hit moving lower. Both stocks are likely to move lower over the course of the next two years.

To start, here is a look at the two respective weekly charts for Constellation Brands and Canopy Growth:

READ FULL ARTICLE HERE